Nvidia's AI monopoly fractures as Google Gemini 3 and Anthropic Claude 4.5 defect to custom TPUs. This seismic shift ...
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), a leader in the development of differentiated targeted radiotherapies, today announced compelling preclinical data for ATNM-400, a first-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback